%0 Journal Article
%T Retrospective analysis of efficacy and safety of Gemcitabinebased chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX
%A Audrey Cabral
%A Lucas Ferreira SantĄŻAna
%A Luciana de Moura Leite
%A Marcos Pedro Guedes Camandaroba
%A Mauro Daniel Spina Donadio
%A Thiago Pimentel Muniz
%A Victor Hugo Fonseca de Jesus
%J SCIE-indexed Journal
%D 2018
%X Advanced pancreatic adenocarcinoma still carries a dismal prognosis; less than 1% of patients are alive 5 years after the discovery of metastasis (1). Despite recent advances in cytotoxic chemotherapy in the first-line setting (2,3), virtually all patients experience disease progression when treated with FOLFIRINOX or Gemcitabine plus Nab-Paclitaxel. Hence, patients frequently need additional treatments to palliate symptoms and extend survival
%U http://jgo.amegroups.com/article/view/22424/html